Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Greystar Appoints Matt DeNoble Senior Director, Life Science Investment
Greystar Real Estate Partners has announced the appointment of Matt DeNoble as senior director of Life Science Investment Management. DeNoble will be responsible for expanding Greystar’s national life sciences strategy, with a focus on the Boston market and other top-tier life science clusters.
DeNoble brings extensive experience in asset management, overseeing leases, dispositions, and recapitalizations. Over the last two decades, DeNoble has overseen 100+ executed leases/renewals totaling more than 2 million square feet, dispositions and recapitalizations of over 3 million square feet and $1.3 billion. He will lead the development of an asset management platform, strengthen tenant relationships, and support new acquisitions and lease-ups.
“I’m excited to continue to elevate Greystar as a national leader in the life sciences space and identify large-scale core opportunities in areas propelled by the innovation economy,” said DeNoble.
